Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms.

ABSTRACT:

SUBMITTER: Halpern AB 

PROVIDER: S-EPMC6442971 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature